                         SEQUENCE LISTING

<110>  King's College London
       Imperial Innovations Limited
 
<120>  Antithrombotic Compounds

<130>  P525138PCT/JSW

<150>  GB 0915519.3
<151>  2009-09-04

<160>  5     

<170>  PatentIn version 3.5

<210>  1
<211>  9
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic construct


<220>
<221>  misc_feature
<222>  (2)..(3)
<223>  Xaa represents cyclohexylalanine

<400>  1

Phe Xaa Xaa Arg Lys Pro Asn Asp Lys 
1               5                   


<210>  2
<211>  23
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic construct

<400>  2

Phe Pro Arg Pro Gly Gly Gly Gly Asp Gly Asp Phe Glu Glu Ile Pro 
1               5                   10                  15      


Glu Glu Tyr Leu Gly Gly Cys 
            20              


<210>  3
<211>  16
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic construct

<400>  3

Ser Ser Lys Ser Pro Ser Lys Lys Asp Asp Lys Lys Pro Gly Asp Cys 
1               5                   10                  15      


<210>  4
<211>  17
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic construct

<400>  4

Gly Ser Ser Lys Ser Pro Ser Lys Lys Lys Lys Lys Lys Pro Gly Asp 
1               5                   10                  15      


Cys 
    


<210>  5
<211>  9
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic construct


<220>
<221>  misc_feature
<222>  (2)..(3)
<223>  Xaa represents cyclohexylalanine

<400>  5

Phe Xaa Xaa Arg Lys Pro Asn Asp Lys 
1               5                   


